Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hangzhou Alltest Biotech CoSHSE:688606 +1.04%53 FCF Yield % is 0.17 as of Jul. 29, 2026, which is 86% below its 10-year median of 1.24. GuruFocus rates SHSE:688606 with a GF Score™ of 53/100 and a GF Value™ of ¥85.89 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Hangzhou Alltest Biotech Co ranks better than 54.34% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Hangzhou Alltest Biotech Co's FCF Yield % or its related term are showing as below:
SHSE:688606'
s FCF Yield % Range Over the Past 10 Years
Min: -11.67 Med: 1.24 Max: 26.75
Current: 0.17
During the past 10 years, the highest FCF Yield % of Hangzhou Alltest Biotech Co was 26.75%. The lowest was -11.67%. And the median was 1.24%.
SHSE:688606's FCF Yield % is ranked better than 54.34% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: -0.405
vs SHSE:688606: 0.17
Hangzhou Alltest Biotech Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hangzhou Alltest Biotech Co FCF Yield % Related Terms
Hangzhou Alltest Biotech Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688606 vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Hangzhou Alltest Biotech Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Alltest Biotech Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Alltest Biotech Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Hangzhou Alltest Biotech Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Alltest Biotech Co (SHSE:688606) has a FCF Yield % of 0.17 as of Jul. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hangzhou Alltest Biotech Co and its competitors. This is 86% below median its historical median of 1.24. According to the industry distribution chart, Hangzhou Alltest Biotech Co ranks #389 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 45.7%.
Is Hangzhou Alltest Biotech Co's FCF Yield % too high?
Hangzhou Alltest Biotech Co's current FCF Yield % of 0.17 is 86% below median its 10-year median of 1.24. Based on the distribution chart, Hangzhou Alltest Biotech Co ranks #389 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hangzhou Alltest Biotech Co has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Alltest Biotech Co's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou Alltest Biotech Co ranks #389 out of 852 companies for FCF Yield %. This puts Hangzhou Alltest Biotech Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hangzhou Alltest Biotech Co and its competitors. Hangzhou Alltest Biotech Co's current FCF Yield % is 0.17, which is 86% below median its own 10-year median of 1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Alltest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Alltest Biotech Co (SHSE:688606) is currently considered Possible Value Trap. The stock's GF Value™ is ¥85.89, compared to a current price of ¥43.92 — trading 48.9% below its estimated fair value. The current FCF Yield % is 0.17, which is 86% below median its 10-year median of 1.24. Hangzhou Alltest Biotech Co's overall GF Score™ is 53/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Hangzhou Alltest Biotech Co (SHSE:688606), the current FCF Yield % is 0.17 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou Alltest Biotech Co (SHSE:688606) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou Alltest Biotech Co stock appears to be undervalued.
The current stock price of ¥43.92 is trading 48.9% below its estimated GF Value™ of ¥85.89.
GuruFocus considers Hangzhou Alltest Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688606:
FCF Yield %: 0.17 (86% below median its 10-year median of 1.24)
GF Value™: ¥85.89 vs. price of ¥43.92 (48.9% below fair value)
No single metric tells the full story. See the SHSE:688606 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688606 has been successfully added to your 
